Klin Padiatr 2015; 227(02): 66-71
DOI: 10.1055/s-0034-1395552
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Diagnostic Value of Immature Myeloid Information in Early-onset Bacterial Infection in Term and Preterm Neonates

Diagnostischer Wert der immature myeloid Information bei der frühen Form der bakteriellen Infektion bei Früh- und Neugeborenen
F. Neunhoeffer
1   Department of Paediatric Cardiology, Pulmology and Paediatric Intensive Care Medicine, University Children’s Hospital Tübingen, Tübingen, Germany
,
M. T. Dabek
2   Neonatology/FIPS, Childrens’ Hospital Heidelberg, Heidelberg, Germany
,
H. Renk
1   Department of Paediatric Cardiology, Pulmology and Paediatric Intensive Care Medicine, University Children’s Hospital Tübingen, Tübingen, Germany
,
P. Rimmele
3   Department of Neonatology, Tübingen University Hospital, Tübingen, Germany
,
C. Poets
3   Department of Neonatology, Tübingen University Hospital, Tübingen, Germany
,
R. Goelz
3   Department of Neonatology, Tübingen University Hospital, Tübingen, Germany
,
T. Orlikowsky
4   Department of Neonatology, University Hospital Aachen, Aachen, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
04 February 2015 (online)

Abstract

Background: For quick detection of neonatal early-onset bacterial infection (EOBI) pro-inflammatory cytokines like Interleukin-6 (IL-6) and Interleukin-8 (IL-8) in combiantion with C-reactive Protein (CRP) have been used. Automated determination of immature myeloid informa-tion (IMI) seems to be an additional useful tool in the diagnosis of NBI.

Objective: To compare the diagnostic value of IMI, I/T-Ratio, plasma IL-6 and IL-8 levels and CRP in term and preterm neonates at time of clinical suspicion of EOBI.

Patients and Methods: 31 preterm and 123 term neonates with clinical and serological signs of EOBI were analysed. 91 preterm and 159 term neonates with risk factors but without proven EOBI served as non-infected controls.

Results: Neonates with EOBI showed significantly elevated IMI levels at time of first clinical suspicion of EOBI (Preterm: 1 028/µL (38-8 759) vs. 289/µL (6-3 126); Term: 1 268/µL (48-14 035) vs. 856/µL (19-5 735); p<0.05 respectively). I/T-Ratio, IL-6, IL-8 and CRP values were significantly higher in preterm and term neonates with EOBI (p<0.05). Sensitivity of IMI at a cut-off level of 650/µL was 84.2% [95%-CI: 74.0–91.6%] in preterm and 65.4% [95%-CI: 56.8–73.3%] in term infants. Specificity was 66.7% [95%-CI: 47.1–82.7%] and 53.9% [95%-CI: 43.8–63.7%], respectively. Combination of different infection parameters improved sensitivity up to 93.5% and specificity up to 98.9%.

Conclusion: The diagnostic value of IMI in diagnosing EOBI in preterm and term neonates is not comparable to IL-6, IL-8 and CRP. Combination of IMI-Channel with IL-6, IL-8 or CRP improves their sensitivity, specificity and predictive value.

Zusammenfassung

Hintergrund: Zur frühzeitigen Erkennung der früheren Form der bakteriellen Infektion (EOBI) werden Interleukin-6 (IL-6) und Interleukin-8 (IL-8) in Kombination mit CRP genutzt. Die automatisierte Bestimmung der immature myeloid information (IMI) scheint ein weiteres nützliches Hilfsmittel in der Diagnostik der NBI zu sein.

Ziel: Vergleich der diagnostischen Wertigkeit von IMI, IL-6 und IL-8 bei Neonaten zum Zeitpunkt des V.a. EOBI.

Patienten und Methode: 31 Frühgeborene und 123 Reifgeborene mit klinischen und laborchemischen Zeichen einer EOBI wurden untersucht. 91 Frühgeborene und 159 Reifgeborene mit Risikofaktoren aber ohne nachgewiesene EOBI dienten als Kontrollgruppe.

Ergebnisse: Neonaten mit EOBI zeigten bei erstem klinischen V.a. EOBI erhöhte IMI-Werte (Preterm: 1 028/µL (38-8 759) vs. 289/µL (6-3 126); Term: 1 268/µL (48-14 035) vs. 856/µL (19-5 735); jeweils p<0,05). I/T-Ratio, IL-6, IL-8 and CRP waren bei Früh- und Reifgeborenen mit EOBI ebenfalls signifikant erhöht (p<0,05). Die Sensitivität der IMI lag bei einem cutt-off von 650/µL bei Frühgeborenen bei 84,2% [95%-CI: 74,0–91,6%]; bei Reifgeborenen bei 65,4% [95%-CI: 56,8–73,3%]. Die Spezifität lag bei in beiden Gruppen bei 66,7% [95%-CI: 47,1–82,7%] bzw. 53,9% [95%-CI: 43,8–63,7%]. Die Kombiantion von IMI mit einem der anderen Infektionsparametert erhöhte die Sensitivität auf bis zu 93,5% und die Spezifität bis zu 98,9%.

Schlussfolgerung: Der diagnostische Wert der IMI zur Erkennung der EOBI ist nicht mit IL-6, IL-8 oder CRP vergleichbar. Eine Kombination von IMI mit IL-6, IL-8 oder CRP verbessert die Sensitivität, die Spezifität und die prädiktiven Werte.

 
  • References

  • 1 Batfalsky A, Lohr A, Heussen N et al. Diagnostic Value of an Interleukin-6 Bedside Test in Term and Preterm Neonates at the Time of Clinical Suspicion of Early- and Late-Onset Bacterial Infection. Neonatology 2012; 102: 37-44
  • 2 Bender L, Thaarup J, Varming K et al. Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull 2008; 55: 219-223
  • 3 Benitz WE, Han MY, Madan A et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998; 102: E41
  • 4 Berner R, Niemeyer CM, Leititis JU et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr-Res 1998; 44: 469-477
  • 5 Celik IH, Demirel FG, Uras N et al. What are the cut-off levels for IL-6 and CRP in neonatal sepsis?. J Clin Lab Anal 2010; 24: 407-412
  • 6 Chiesa C, Signore F, Assumma M et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders. Clin Chem 2001; 47: 1016-1022
  • 7 Cimenti C, Erwa W, Herkner K et al. The predictive value of immature granulocyte count and immature myeloid information in the diagnosis of neonatal sepsis. Clin Chem Lab Med 2012; 50: 1429-1432
  • 8 Døllner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001; 54: 1251-1257
  • 9 Ehl S, Gering B, Bartmann P et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997; 99: 216-221
  • 10 Escobar GJ. Effect of the systemic inflammatory response on biochemical markers of neonatal bacterial infection: a fresh look at old confounders. Clin Chem 2003; 49: 21-22
  • 11 Fernandes B, Hamaguchi Y. Automated enumeration of immature granulocytes. Am J Clin Pathol 2007; 128: 454-463
  • 12 Franz AR, Kron M, Pohlandt F et al. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr Infect Dis J 1999; 18: 666-671
  • 13 Franz AR, Steinbach G, Kron M et al. Interleukin-8: a valuable tool to restrict antibiotic therapy in newborn infants. Acta Paediatr 2001; 90: 1025-1032
  • 14 Franz AR, Sieber S, Pohlandt F et al. Whole blood interleukin 8 and plasma interleukin 8 levels in newborn infants with suspected bacterial infection. Acta Pediatr 2004; 93: 648-653
  • 15 Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI) . Bakterielle Infektionen bei Neugeborenen. AWMF-Leitlinien-Register-Nr. 024/008 2006; http://www.uni-duesseldorf.de/AWMF/ll/024-008.htm
  • 16 Gille C, Leiber A, Spring B et al. Diminished phagocytosis-induced cell death (PICD) in neonatal monocytes upon infection with Escherichia coli. Pediatr Res 2008; 63: 33-38
  • 17 Gille C, Steffen F, Lauber K et al. Clearance of apoptotic neutrophils is diminished in cord blood monocytes and does not lead to reduced IL-8 production. Pediatr Res. 2009; 66: 507-512
  • 18 Messer J, Eyer D, Donato L et al. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 1996; 129: 574-580
  • 19 Gottfried EL. Lipids of human leukocytes: relation to celltype. J Lipid Res 1967; 8: 321-327
  • 20 Haque KN. Neonatal sepsis in the very low birth weight preterm infants: part 2: review of defi nition, diagnosis and management. J Med Sci 2010; 3: 11-27
  • 21 Hengst JM. The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care 2003; 3: 3-213
  • 22 Hsu KK, Pelton SI, Shapiro DS. Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis. Diagn Microbiol Infect Dis 2003; 45: 23-27
  • 23 Krediet T, Gerards L, Fleer A et al. The predictive value of CRP and I/T-ratio in neonatal infection. J Perinat Med 1992; 20: 479-485
  • 24 Laborada G, Rego M, Jain A et al. Diagnostic value of cytokines and C-reactive protein in the first 24 hours of neonatal sepsis. Am J Perinatol 2003; 20: 491-501
  • 25 Manroe BL, Weinberg AG, Rosenfeld CR et al. The neonatal blood count in health and disease. Reference values for neutrophilic cells. J Pediatr 1979; 95: 89-98
  • 26 Martin H, Olander B, Norman M. “Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-α in the diagnosis of early-onset neonatal sepsis”. Pediatrics 2001; 108: 1-6
  • 27 Mathers NJ, Pohlandt F. Diagnostic audit of C-reactive protein in neonatal infection. Eur J Pediatr 1987; 146: 147-2151
  • 28 Muenzenmaier M, Depperschmid M, Gille C et al. C-Reactive Protein, Detected with a Highly Sensitive Assay, in Non-Infected Newborns and Those with Early Onset Infection. Transfus Med Hemother 2008; 35: 37-41 [Epub 2008 Jan 15]
  • 29 Neunhoeffer F, Lipponer D, Eichner M et al. Influence of Gestational Age, Cesarean Section and Hematocrit on lnterleukin-8 Concentrations in Plasma and Detergent-Lysed Whole Blood of Noninfected Newborns. Transfus Med Hemother 2011; 38: 183-189 [Epub 2011 May 13]
  • 30 Ng PC. Diagnostic markers of infection in neonates. A comprehensive review summarizing the evolution of infection markers in neonatology over the past two decades. Arch Dis Child Fetal Neonatal Ed 2004; 89: F229-F235
  • 31 Ng PC, Cheng SH, Chui KM et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1997; 77: F221-F227
  • 32 Orlikowsky TW, Neunhoeffer F, Goelz R et al. Evaluation of IL-8-concentrations in plasma and lysed EDTA-blood in healthy neonates and those with suspected early onset bacterial infection. Pediatr Res 2004; 56: 1-6
  • 33 Ottolini MC, Lundgren K, Mirkinson LJ et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic newborn. Pediatr Infect Dis J 2003; 22: 430-2434
  • 34 Schultz C, Rott C, Temming P et al. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002; 51: 317-322
  • 35 Schultz C, Temming P, Bucsky P et al. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2004; 135: 130-136
  • 36 Stoll BJ, Gordon T, Korones SB et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 72-80
  • 37 Stoll BJ, Hansen NI, S´anchez PJ. “Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues”. Pediatrics 2011; 127: 817-826
  • 38 Stoll BJ, Hansen NI, Higgins RJ. “Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of Gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003”. Pediatric Infectious Disease Journal 2005; 24: 635-639